June 2025

Orion’s collaboration partner Bayer announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has recommended darolutamide, an oral androgen receptor inhibitor , plus androgen deprivation therapy for marketing authorisation in the European Union for the treatment of patients with metastatic hormone-sensitive prostate cancer

A team of physicians from Bochum are the first to successfully use CAR T-cell therapy to treat two patients with a rare autoimmune disease of the peripheral nervous system. This treatment modifies endogenous immune cells such that they can specifically target and eliminate B lymphocytes, which are here the origin of autoimmunity.

Assessment of vacancies of para-medical categories done by Zonal Railways/PUs in the Indent Management module of HRMS has been examined in Railway Board.

PG in Science M.Pharm, Life Science, M.Sc. Biotech, Zoology, Botany, etc. Or Graduation in Science (B.Pharm, Life Science, B.Sc. Biotech, Zoology, Botany, etc with 3 years’ Experience in relevant field. 

Doctoral Degree in Science, Pharma with specialization in Phytochemistry, Natural Products, Organic Chemistry, Analytical Chemistry, Microbiology, Biotechnology.

First class in M.Pharm. or M.S. in Pharmaceutics, Drug delivery, Pharmaceutical Technology, Nanomedicines, or equivalent from a recognized Institute, University.

Post-Graduation in life science. Graduate degree in science with PG Diploma in Clinical Research. Experience of one year in relevant filed is desirable.

Masters, Integrated Masters in Natural or Agricultural or Pharmaceutical Sciences, MVSc, Animal Sciences OR Bachelors degree in Engineering or Technology or Medicine from a recognized University.

MSc, M. Tech. in Life Sciences or allied subjects from a recognized University with two years of post-qualification research experience in Molecular virology.